UNVC Stock Overview
Univec, Inc., through its subsidiaries, produces, licenses, and markets medical products in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Univec, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0055 |
| 52 Week High | US$0.015 |
| 52 Week Low | US$0.0025 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 4.76% |
| 1 Year Change | -57.69% |
| 3 Year Change | -89.56% |
| 5 Year Change | 61.76% |
| Change since IPO | -99.94% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| UNVC | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 14.6% | 1.4% | 1.2% |
| 1Y | -57.7% | -0.7% | 24.7% |
Return vs Industry: UNVC underperformed the US Medical Equipment industry which returned -0.7% over the past year.
Return vs Market: UNVC underperformed the US Market which returned 24.7% over the past year.
Price Volatility
| UNVC volatility | |
|---|---|
| UNVC Average Weekly Movement | 30.2% |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: UNVC's share price has been volatile over the past 3 months.
Volatility Over Time: UNVC's weekly volatility has increased from 25% to 30% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | n/a | David Dalton | www.univec.com |
Univec, Inc., through its subsidiaries, produces, licenses, and markets medical products in the United States and internationally. It primarily provides auto-disable and safety syringes. The company offers 1 cc AD-syringe for aspirating and non-aspirating applications, which are used for dispensing dosages of allergy, immunization, and insulin medicines.
Univec, Inc. Fundamentals Summary
| UNVC fundamental statistics | |
|---|---|
| Market cap | US$13.87m |
| Earnings (TTM) | -US$650.34k |
| Revenue (TTM) | US$28.63k |
0.0x
P/S Ratio0.0x
P/E RatioIs UNVC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| UNVC income statement (TTM) | |
|---|---|
| Revenue | US$28.63k |
| Cost of Revenue | US$42.94k |
| Gross Profit | -US$14.31k |
| Other Expenses | US$636.03k |
| Earnings | -US$650.34k |
Last Reported Earnings
Sep 30, 2007
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did UNVC perform over the long term?
See historical performance and comparison